Âé¶ą´«Ă˝É«ÇéƬ

Annual Meeting

Enzymes: Still cool after all these years

Learn about the Discover BMB 2024 symposium on enzymes
Shelley Copley Hung-wen (Ben) Liu
By Shelley Copley and Hung-wen (Ben) Liu
Sept. 12, 2023

The first enzyme was discovered in 1833, almost 200 years ago and long before the nature of proteins was appreciated. The field of enzymology came into its own in the 20th century. Technological advances in the hands of creative enzymologists led to an ever-growing understanding of how enzymes achieve enormous rate accelerations as well as the structural basis for substrate specificity and allosteric regulation.

Submit an abstract

Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.

Enzymologists continue to break new ground as we enter the 21st century. Our session at Discover BMB will feature new work on enzyme functions, mechanisms and applications.

Our first group of speakers will focus on enzymes that deal with problems caused by misbehaving metabolites. They will describe how enzymes can protect unstable intermediates and repair damaged metabolites.  Our second group will explore the potential of using enzymes for biodegradation and green biosynthesis of chemicals currently produced from petrochemicals. Our final group will focus on enzymes that catalyze novel reactions, pushing the boundaries of chemistry accessible through biocatalysts.

Keywords: Substrate channeling, metabolite repair, biodegradation, green chemistry, natural product biosynthesis, radical chemistry.

Who should attend: Anyone who appreciates the awesome power of enzyme catalysis.

Theme song: by Paul Simon, because enzymes are crazy-efficient catalysts

This session is powered by the ribosome, which produces the enzymes that make life possible.

Cool and novel enzymes

Enzymatic control of problematic intermediates

Chair: Hung-Wen (Ben) Liu

Shelley D. CopleyUniversity of Colorado Boulder

Tom NiehausUniversity of Minnesota, Twin Cities

Shelley MinteerUniversity of Utah

Carole LinsterUniversity of Luxembourg

Enzymes for a sustainable future

Chair: Shelley D. Copley

Gregg BeckhamNational Renewable Energy Laboratory

Larry WackettUniversity of Minnesota

Michelle Chang, University of California, Berkeley

Raquel Lieberman, Georgia Institute of Technology

New and unusual enzymatic transformations

Chair: Michelle Chang

Hung-wen (Ben) LiuUniversity of Texas at Austin

Aimin LiuUniversity of Texas at San Antonio

Sara O'ConnorMax Planck Institute for Chemical Ecology

Wenjun ZhangUniversity of California, Berkeley

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Shelley Copley
Shelley Copley

Shelley Copley is a professor in the molecular, cellular and developmental biology department and a fellow of the Cooperative Institute for Environmental Sciences at the University of Colorado Boulder.

Hung-wen (Ben) Liu
Hung-wen (Ben) Liu

Hung-wen (Ben) Liu is a professor in the College of Pharmacy and chemistry department of the University of Texas at Austin.

Related articles

Out with the old, in with the nucleus
Glen Liszczak & Aaron Johnson
Biochemists face the climate challenge
Karla Neugebauer & Kayunta Johnson–Winters
Building natural products
Yi Tang & Katherine Ryan
Enzymes show off new moves
Tadhg Begley & Catherine Drennan

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.